Pediatric Psoriasis: From New Insights into Pathogenesis to Updates on Treatment

Psoriasis is a chronic inflammatory systemic disease primarily affecting the skin, but which often involves considerable comorbidities as well. One-third of psoriasis cases start during childhood. In pediatric psoriasis, an association with several medical comorbidities is also indicated. Furthermor...

Full description

Bibliographic Details
Main Authors: Hye One Kim, Seok Young Kang, Jin Cheol Kim, Chun Wook Park, Bo Young Chung
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/9/8/940
_version_ 1797524585824911360
author Hye One Kim
Seok Young Kang
Jin Cheol Kim
Chun Wook Park
Bo Young Chung
author_facet Hye One Kim
Seok Young Kang
Jin Cheol Kim
Chun Wook Park
Bo Young Chung
author_sort Hye One Kim
collection DOAJ
description Psoriasis is a chronic inflammatory systemic disease primarily affecting the skin, but which often involves considerable comorbidities as well. One-third of psoriasis cases start during childhood. In pediatric psoriasis, an association with several medical comorbidities is also indicated. Furthermore, because of its chronic nature and frequent relapses, psoriatic patients tend to require long-term treatment and experience negative impacts on their quality of life. Considering the different clinical characteristics of pediatric psoriasis, it has recently been presented that the pathogenesis of pediatric psoriasis is distinct from adult psoriasis. Treatment for pediatric psoriasis usually involves the same methods as for adults. However, most treatments in pediatric psoriasis are used off-label and research in this regard is still lacking. Targeted therapies involving newly developed biologics are also increasingly being applied to psoriasis in children. This review summarizes the clinical characteristics of pediatric psoriasis and focuses mainly on the updated concepts of pathogenesis and treatments in pediatric psoriasis. This was undertaken to widen the understanding of these relevant aspects and to provide better management of pediatric psoriasis by clinicians.
first_indexed 2024-03-10T08:59:33Z
format Article
id doaj.art-880a8a336aba40a2a9d4d00285ad5f26
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-10T08:59:33Z
publishDate 2021-08-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-880a8a336aba40a2a9d4d00285ad5f262023-11-22T06:52:19ZengMDPI AGBiomedicines2227-90592021-08-019894010.3390/biomedicines9080940Pediatric Psoriasis: From New Insights into Pathogenesis to Updates on TreatmentHye One Kim0Seok Young Kang1Jin Cheol Kim2Chun Wook Park3Bo Young Chung4Department of Dermatology, Hallym University Kangnam Sacred Heart Hospital, Seoul 07441, KoreaDepartment of Dermatology, Hallym University Kangnam Sacred Heart Hospital, Seoul 07441, KoreaDepartment of Dermatology, Hallym University Kangnam Sacred Heart Hospital, Seoul 07441, KoreaDepartment of Dermatology, Hallym University Kangnam Sacred Heart Hospital, Seoul 07441, KoreaDepartment of Dermatology, Hallym University Kangnam Sacred Heart Hospital, Seoul 07441, KoreaPsoriasis is a chronic inflammatory systemic disease primarily affecting the skin, but which often involves considerable comorbidities as well. One-third of psoriasis cases start during childhood. In pediatric psoriasis, an association with several medical comorbidities is also indicated. Furthermore, because of its chronic nature and frequent relapses, psoriatic patients tend to require long-term treatment and experience negative impacts on their quality of life. Considering the different clinical characteristics of pediatric psoriasis, it has recently been presented that the pathogenesis of pediatric psoriasis is distinct from adult psoriasis. Treatment for pediatric psoriasis usually involves the same methods as for adults. However, most treatments in pediatric psoriasis are used off-label and research in this regard is still lacking. Targeted therapies involving newly developed biologics are also increasingly being applied to psoriasis in children. This review summarizes the clinical characteristics of pediatric psoriasis and focuses mainly on the updated concepts of pathogenesis and treatments in pediatric psoriasis. This was undertaken to widen the understanding of these relevant aspects and to provide better management of pediatric psoriasis by clinicians.https://www.mdpi.com/2227-9059/9/8/940psoriasispediatricchildhoodpathogenesistopical treatmentsystemic treatment
spellingShingle Hye One Kim
Seok Young Kang
Jin Cheol Kim
Chun Wook Park
Bo Young Chung
Pediatric Psoriasis: From New Insights into Pathogenesis to Updates on Treatment
Biomedicines
psoriasis
pediatric
childhood
pathogenesis
topical treatment
systemic treatment
title Pediatric Psoriasis: From New Insights into Pathogenesis to Updates on Treatment
title_full Pediatric Psoriasis: From New Insights into Pathogenesis to Updates on Treatment
title_fullStr Pediatric Psoriasis: From New Insights into Pathogenesis to Updates on Treatment
title_full_unstemmed Pediatric Psoriasis: From New Insights into Pathogenesis to Updates on Treatment
title_short Pediatric Psoriasis: From New Insights into Pathogenesis to Updates on Treatment
title_sort pediatric psoriasis from new insights into pathogenesis to updates on treatment
topic psoriasis
pediatric
childhood
pathogenesis
topical treatment
systemic treatment
url https://www.mdpi.com/2227-9059/9/8/940
work_keys_str_mv AT hyeonekim pediatricpsoriasisfromnewinsightsintopathogenesistoupdatesontreatment
AT seokyoungkang pediatricpsoriasisfromnewinsightsintopathogenesistoupdatesontreatment
AT jincheolkim pediatricpsoriasisfromnewinsightsintopathogenesistoupdatesontreatment
AT chunwookpark pediatricpsoriasisfromnewinsightsintopathogenesistoupdatesontreatment
AT boyoungchung pediatricpsoriasisfromnewinsightsintopathogenesistoupdatesontreatment